• October 17, 2024
  New England Hemolytics has been invited to present a poster describing their breakthrough technology at the BARDA Innovation Symposium 2024.  This event will showcase early-stage health security innovations in order to facilitate collaborations for the innovators, funders, and industry partners.    
  Event details: BARDA Innovation Symposium  Wednesday, November 6, 2024, 9 am – 5 pm, 400 7th St SW, Washington, DC 20024 
  https://drive.hhs.gov/innovation2024.html
• October 16, 2024
  New England Hemolytics will be attending Biofuture in NYC, which runs October 28-30. https://biofuture.com/John Nobile, Founder and CEO, will be presenting on October 30, 10AMOnsite meetings may be scheduled by attendees through hellopartnering.comor by contacting us directly at info@newenglandhemolytics.com
• September 14, 2024
  New England Hemolytics has been awarded a National Science Foundation SBIR Phase 1 research grant to advance our novel whole blood extraction technology.
  Read more
• New England Hemolytics Inc. will be attending Biotech Showcase January  8-10, 2024
  Hilton San Francisco - Union Square
  333 O'Farrell Street, Ballroom Level
  San Francisco, CA 94102
  Meeting slots available for in-person or virtual partnering, or learn about our company & revolutionary technology platform by attending our presentation at Seed Showcase:
  ‍Tuesday, January 09, at 10:20AM in room Franciscan D.
  https://informaconnect.com/biotech-showcase/
• October 20, 2023 - NEH presents poster at 2023 AACC Preanalytical Phase Conference in Philadelphia, PA
  Link to poster
• October 6, 2023 - NEH attends Biofuture in NYC
  Thanks to all who attended our October 2023 presentation at Biofuture!
• June 12, 2023
  New England Hemolytics appoints Hayden Jeffreys as a Non-Executive Director
  Read more